Antiangiogenic Peptide Vaccine Therapy in Treating Patient With Hepatocellular Carcinoma

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01266707
Recruitment Status : Unknown
Verified December 2010 by Fukushima Medical University.
Recruitment status was:  Recruiting
First Posted : December 24, 2010
Last Update Posted : December 24, 2010
Human Genome Center, Institute of Medical Science, University of Tokyo
Information provided by:
Fukushima Medical University